Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.

Chen X, Li Z, Liang M, Zhang Z, Zhu D, Lin B, Zhou R, Lu Y

Open source

DOI
10.1186/s12957-023-03078-7
Published
2023 Jun 30
Container
World journal of surgical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12957-023-03078-7,
  title = {Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.},
  author = {Chen X and Li Z and Liang M and Zhang Z and Zhu D and Lin B and Zhou R and Lu Y},
  year = {2023},
  journal = {World journal of surgical oncology},
  doi = {10.1186/s12957-023-03078-7},
  url = {https://doi.org/10.1186/s12957-023-03078-7}
}

RIS

TY  - JOUR
TI  - Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
AU  - Chen X
AU  - Li Z
AU  - Liang M
AU  - Zhang Z
AU  - Zhu D
AU  - Lin B
AU  - Zhou R
AU  - Lu Y
PY  - 2023
JO  - World journal of surgical oncology
DO  - 10.1186/s12957-023-03078-7
UR  - https://doi.org/10.1186/s12957-023-03078-7
ER  - 

APA

X, C., Z, L., M, L., Z, Z., D, Z., B, L., R, Z., & Y, L. (2023). Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.. World journal of surgical oncology. https://doi.org/10.1186/s12957-023-03078-7

Source records